Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-733-6 | CAS number: 110-05-4
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No substance specific data on metabolism and kinetics are available.
Based on physical-chemical characteristics, particularly water solubility (ca. 170 mg/l), octanol-water partition coefficient (experimental log Kow 3.2,) and vapour pressure (approximately 31 hPa at 25°C), some level of absorption by oral, dermal and inhalation routes is expected. This is supported by results of the OECD 422 study in rats in which systemic effects (increased liver and kidney weights) were found after oral dosing for at least 28 days. It is further supported by interim results of an OECD 413 study in which increased liver and kidney weights were found after inhalation exposure for 90 days. The substance is not a skin irritant; therefore no increase of skin absorption is expected.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
No substance specific data on metabolism and kinetics are available.
Based on physical-chemical characteristics, particularly water solubility (ca. 170 mg/l), octanol-water partition coefficient (experimental log Kow 3.2,) and vapour pressure (approximately 31 hPa at 25°C), some level of absorption by oral, dermal and inhalation routes is expected. This is supported by results of the OECD 422 study in rats in which systemic effects (increased liver and kidney weights) were found after oral dosing for at least 28 days. It is further supported by interim results of an OECD 413 study in which increased liver and kidney weights were found after inhalation exposure for 90 days. The substance is not a skin irritant; therefore no increase of skin absorption is expected.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
